(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPSUMIT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OPSUMIT

ST13

US500000090653209

Class

44

Filing

90653209

Registration

6697798

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

04/12/2022

Trademark type

Combined

Nice classes

44

Filing date

04/18/2021

Registration date

04/12/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/12/2022

Last transaction

04/12/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

11/04/2013

First use in commerce

11/04/2013

Drawing code

3

Owner type

03

Owner location

Allschwil, CH

Examiner

VO, KOMAL

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "OPSUMIT" and an arrow design above the wording.

Holders and representatives

Holders

Actelion Pharmaceuticals Ltd.

Representatives

Cheryl Foytlin JOHNSON & JOHNSON

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing medical information regarding pharmaceutical products and healthcare to healthcare professionals and patients

Publications

History of USPTO decisions and trademark events.

18 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

04/12/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/25/2022

PUBO

PUBLISHED FOR OPPOSITION

01/25/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/20/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

12/16/2021

GRML

CORRESPONDENCE E-MAILED

12/16/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/16/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/16/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/16/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/16/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/14/2021

GNRT

NON-FINAL ACTION E-MAILED

12/14/2021

CNRT

NON-FINAL ACTION WRITTEN

12/14/2021

DOCK

ASSIGNED TO EXAMINER

12/09/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/27/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/26/2021

NWAP

NEW APPLICATION ENTERED

04/21/2021

Continuous trademark protection

Get notified about every new filing that threatens OPSUMIT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.